The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of pemigatinib for pre-treated glioblastoma or other gliomas with activating FGFR1-3 alterations: Results from FIGHT-209.
 
Enrico Franceschi
Consulting or Advisory Role - Genenta Science
(OPTIONAL) Uncompensated Relationships - Incyte
 
Martin Van Den Bent
Consulting or Advisory Role - Anheart Therapeutics; Boehringer Ingelheim; chimerix; Fore Biotherapeutics; Genenta Science; Incyte; Mundipharma; Nuvation Bio; Servier
Travel, Accommodations, Expenses - Servier
 
Marc Sanson
No Relationships to Disclose
 
Andrew Lassman
Consulting or Advisory Role - Alpha Detail; Bluestar Bioadvisors; Curio Science; Fore Biotherapeutics; Gerson Lehrman Group; Global Coalition for Adaptive Research; Guidepoint Global; Modifi Bio; Orbus Therapeutics; Reach Market Research; Sapience Therapeutics; Servier
Research Funding - Abbott Laboratories (Inst); Abbvie (Inst); Aeterna Zentaris (Inst); AstraZeneca (Inst); Bayer (Inst); Biohaven Pharmaceuticals (Inst); BMS (Inst); Chimerix (Inst); Corden (Inst); DelMar Pharmaceuticals (Inst); Genentech/Roche (Inst); Global Coalition for Adaptive Research (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Kintara Therapeutics (Inst); NextSource (Inst); Novartis (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Polaris (Inst); QED Therapeutics (Inst); Servier (Inst); VBI Vaccines (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Anheart Therapeutics; Foundation Medicine; Gilead Sciences; Global Coalition for Adaptive Research; Incyte; Modifi Bio; Moving Innovation and Technology; Orbus Therapeutics; Sapience Therapeutics; Servier; VBI Vaccines
 
Giuseppe Lombardi
Consulting or Advisory Role - Bayer; Brain Health Solutions; Braun Travacare; CarThera; Cecava; Genenta Science; GlaxoSmithKline; health4u; Janssen Oncology; Novartis; Novocure; SERVIER; TME Pharma
Speakers' Bureau - Bayer; Novocure; SERVIER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; SERVIER
 
Maria Vieito Villar
Consulting or Advisory Role - BMS
Speakers' Bureau - Novocure
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst); Roche; Roche/Genentech (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - BMS GmbH & Co. KG (Inst); Debiopharm Group (Inst); HUTCHMED (Inst); Incyte (Inst); Mundipharma (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst); SERVIER (Inst); Taiho Oncology (Inst)
 
Roy Strowd
Consulting or Advisory Role - Alexion Pharmaceuticals; Monteris Medical; Monteris Medical; Novocure; SpringWorks Therapeutics
Research Funding - Alpha Omega Alpha; American Board of Psychiatry and Neurology; Jazz Pharmaceuticals; NIH; Southeastern Brain Tumor Foundation
Patents, Royalties, Other Intellectual Property - Elsevier, book royalties; Lecturio, lecture royalties
Other Relationship - American Academy of Neurology (AAN)
 
Juan Manuel Sepulveda Sanchez
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - BMS; Cantex Pharmaceuticals; CeCaVa; Novocure; Servier
Speakers' Bureau - SERVIER
Research Funding - Cantex Pharmaceuticals (Inst); IDP Pharmaceuticals (Inst); Pfizer (Inst); Tilray (Inst); Varsity Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Catherine McBain
No Relationships to Disclose
 
Rikke Dahlrot
No Relationships to Disclose
 
Estela Pineda
No Relationships to Disclose
 
Delphine Larrieu
No Relationships to Disclose
 
Alessia Pellerino
No Relationships to Disclose
 
Yoshitaka Narita
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Nihon Medi-Physics; Novocure; Ono Pharmaceutical; SERVIER; Sumitomo Dainippon Pharma Oncology
Consulting or Advisory Role - SERVIER; Sumitomo Pharma Oncology; SymBio Pharmaceuticals
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Incyte Japan (Inst); MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. (Inst); novocure (Inst); Ohara Pharmaceutical (Inst); Ono Pharmaceutical (Inst); PPD Global (Inst); Sumitomo Pharma Oncology (Inst); Taiho Pharmaceutical (Inst)
 
Stephen Bagley
Consulting or Advisory Role - KIYATEC; Modifi Bio; SERVIER; Telix Pharmaceuticals; Third Rock Ventures
Research Funding - C2i genomics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kite, a Gilead company; Kite, a Gilead company; Lilly (Inst); Novocure (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of intellectual property of the University of Pennsylvania licensed to Novartis: Combination Therapies of EGFRvIII Chimeric Antigen Receptors and PD-1 Inhibitors, US. Patent No. 62/809,245.
Travel, Accommodations, Expenses - Northwest Biotherapeutics
 
Lalanthica Yogendran
No Relationships to Disclose
 
Natalia Oliveira
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Yufei Guo
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Louis Viviers
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)